BR112013030682A2 - ensaio e métodos de uso da lisil-oxidase-like 2 - Google Patents

ensaio e métodos de uso da lisil-oxidase-like 2

Info

Publication number
BR112013030682A2
BR112013030682A2 BR112013030682A BR112013030682A BR112013030682A2 BR 112013030682 A2 BR112013030682 A2 BR 112013030682A2 BR 112013030682 A BR112013030682 A BR 112013030682A BR 112013030682 A BR112013030682 A BR 112013030682A BR 112013030682 A2 BR112013030682 A2 BR 112013030682A2
Authority
BR
Brazil
Prior art keywords
test
methods
lysyl oxidase
lysyl
oxidase
Prior art date
Application number
BR112013030682A
Other languages
English (en)
Portuguese (pt)
Inventor
Jason Chien
Jeffrey D Bornstein
Joanne I Adamkewicz
Lixin Shao
Susan K Lyman
Victoria Smith
Xiaoming Li
Original Assignee
Gilead Biologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46208194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013030682(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Biologics Inc filed Critical Gilead Biologics Inc
Publication of BR112013030682A2 publication Critical patent/BR112013030682A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Silicon Polymers (AREA)
BR112013030682A 2011-06-01 2012-06-01 ensaio e métodos de uso da lisil-oxidase-like 2 BR112013030682A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161492210P 2011-06-01 2011-06-01
US201161550895P 2011-10-24 2011-10-24
US201161578813P 2011-12-21 2011-12-21
PCT/US2012/040585 WO2012167181A1 (en) 2011-06-01 2012-06-01 Lysyl oxidase-like 2 assay and methods of use thereof

Publications (1)

Publication Number Publication Date
BR112013030682A2 true BR112013030682A2 (pt) 2016-12-06

Family

ID=46208194

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013030682A BR112013030682A2 (pt) 2011-06-01 2012-06-01 ensaio e métodos de uso da lisil-oxidase-like 2

Country Status (25)

Country Link
US (3) US20120309020A1 (https=)
EP (1) EP2714744A1 (https=)
JP (3) JP2014523521A (https=)
KR (1) KR20140048156A (https=)
CN (1) CN103946241A (https=)
AP (1) AP2013007285A0 (https=)
AR (1) AR086657A1 (https=)
AU (2) AU2012261883A1 (https=)
BR (1) BR112013030682A2 (https=)
CA (1) CA2837534A1 (https=)
CL (1) CL2013003445A1 (https=)
CO (1) CO6940375A2 (https=)
CR (1) CR20130657A (https=)
EA (1) EA201391627A1 (https=)
EC (1) ECSP13013092A (https=)
IL (1) IL229631A0 (https=)
MA (1) MA35212B1 (https=)
MD (1) MD20130098A2 (https=)
MX (1) MX2013013905A (https=)
PE (1) PE20141450A1 (https=)
PH (1) PH12013502490A1 (https=)
TW (1) TW201319572A (https=)
UY (1) UY34115A (https=)
WO (1) WO2012167181A1 (https=)
ZA (1) ZA201308812B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
ES2700141T3 (es) 2007-08-02 2019-02-14 Gilead Biologics Inc Anticuerpos inhibidores LOXL2 y usos de los mismos
WO2010080769A2 (en) 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
SG178845A1 (en) 2009-08-21 2012-04-27 Gilead Biologics Inc Catalytic domains from lysyl oxidase and loxl2
BR112012019693A2 (pt) * 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
SG11201503065PA (en) * 2012-10-30 2015-05-28 Gilead Sciences Inc Therapeutic and diagnostic methods related to lysyl oxidase-like 2 (loxl2)
WO2015187499A1 (en) 2014-06-03 2015-12-10 Gilead Sciences, Inc. Use of an ask1 inhibitor for the treatment of liver disease, optionally in combination with a loxl2 inhibitor
KR20170018383A (ko) * 2014-06-11 2017-02-17 길리애드 사이언시즈, 인코포레이티드 심혈관 질환의 치료 방법
MA41252A (fr) 2014-12-23 2017-10-31 Gilead Sciences Inc Formes solides d'un inhibiteur d'ask 1
AU2017228371A1 (en) 2016-03-04 2018-09-13 Gilead Sciences, Inc. Compositions and combinations of autotaxin inhibitors
EP3440113A1 (en) 2016-04-08 2019-02-13 Gilead Sciences, Inc. Compositions and methods for treating cancer, inflammatory diseases and autoimmune diseases
GB201704206D0 (en) 2017-03-16 2017-05-03 Nordic Bioscience As Lysyl oxidase like-2 assay
US20230152330A1 (en) * 2021-11-17 2023-05-18 AmMax Bio, Inc. Detection and treatment of idiopathic pulmonary fibrosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352862B1 (en) * 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
FI92882C (fi) * 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US20030114410A1 (en) * 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
ES2700141T3 (es) * 2007-08-02 2019-02-14 Gilead Biologics Inc Anticuerpos inhibidores LOXL2 y usos de los mismos
JP2010038735A (ja) * 2008-08-05 2010-02-18 Terumo Corp 腹膜機能の評価方法および腹膜機能評価用イムノクロマト試験紙
NZ625850A (en) * 2009-08-21 2015-12-24 Gilead Biologics Inc Methods and compositions for treatment of pulmonary fibrotic disorders
BR112012019693A2 (pt) * 2010-02-04 2017-06-20 Gilead Biologics Inc anticorpos que se ligam à lisil oxidase-like 2 (loxl2) e métodos de uso para eles.
WO2012154432A2 (en) * 2011-05-10 2012-11-15 Borgwarner Inc. Turbocharger with variable turbine geometry

Also Published As

Publication number Publication date
US20170269085A1 (en) 2017-09-21
ZA201308812B (en) 2014-08-27
PE20141450A1 (es) 2014-11-06
TW201319572A (zh) 2013-05-16
PH12013502490A1 (en) 2014-01-20
AP2013007285A0 (en) 2013-11-30
ECSP13013092A (es) 2014-08-29
UY34115A (es) 2013-01-03
NZ618682A (en) 2016-04-29
EA201391627A1 (ru) 2014-08-29
CA2837534A1 (en) 2012-12-06
CN103946241A (zh) 2014-07-23
AU2016244254A1 (en) 2016-11-03
MD20130098A2 (ro) 2014-06-30
CL2013003445A1 (es) 2014-07-25
IL229631A0 (en) 2014-01-30
AU2012261883A1 (en) 2013-05-02
EP2714744A1 (en) 2014-04-09
JP2014523521A (ja) 2014-09-11
KR20140048156A (ko) 2014-04-23
MA35212B1 (fr) 2014-06-02
WO2012167181A1 (en) 2012-12-06
JP2016164578A (ja) 2016-09-08
AU2016244254B2 (en) 2018-10-18
CO6940375A2 (es) 2014-05-09
MX2013013905A (es) 2014-05-14
JP2018049033A (ja) 2018-03-29
AR086657A1 (es) 2014-01-15
US20140206017A1 (en) 2014-07-24
CR20130657A (es) 2014-05-16
US20120309020A1 (en) 2012-12-06

Similar Documents

Publication Publication Date Title
BR112013030682A2 (pt) ensaio e métodos de uso da lisil-oxidase-like 2
BR112012018329A2 (pt) agentes de coloração e métodos de uso destes
BR112013014119A2 (pt) novos moduladores e métodos de uso
BR112013007506A2 (pt) piridinonas/pirazinonas - métodos de criação e de uso
BRPI0916769A2 (pt) derivados de benzilbenzeno deuterados e métodos de uso
BRPI1014544A2 (pt) anticorpors anti-il-17f e metodos de uso dos mesmos
BRPI0910852A2 (pt) composições contendo lipídios e métodos de uso das mesmas
SMT201600228B (it) Sonda da focoemulsificazione bilanciata
CO6801741A2 (es) Derivados c4-monometil triterpenoides y sus métodos de uso
BRPI1011384A2 (pt) pro-proteinas e seus metodos de uso
BRPI1005292A2 (pt) composição de decapagem e uso da composição
CO6801742A2 (es) Derivados de ácido 3-fenilpropiónico ramificados y su uso
PT2585437E (pt) Compostos de tioacetato, composições e métodos de uso
BR112014028366A2 (pt) anticorpos anti-ly6e e imunoconjugados e métodos de uso
BRPI0922708A2 (pt) peptídeos mini-hepcidina e métodos de uso do mesmo
CO6862148A2 (es) Composiciones transdérmicas de ibuprofeno y métodos de uso de las mismas
BR112013014231A2 (pt) composição de higiene pessoal e uso da composição de higiene pessoal
AT506816B1 (de) Vlf-prüfgenerator
BR112013008696A2 (pt) instrumento de redução de haste e métodos de redução de haste
BR112014009837A2 (pt) uso eficaz da levedura e extrato de levedura
BR112015002331A2 (pt) revestimento termocrômico reversível e método de uso do mesmo
BRPI0913086A2 (pt) Composições antimicrobianas e métodos de uso
BR112014000329A2 (pt) método de análise de distúrbios cardiovasculares e uso do mesmo
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
BR112013010331A2 (pt) composições adesivas crepadas e métodos de uso dessas composições

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]